Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Omoto

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
British Journal of Haematology|April 1, 1997
Re-induction of complete remission with a new synthetic retinoid, Am-80, for relapse of acute promyelocytic leukaemia previously treated with all-trans retinoic acidM Takeuchi, T Yano, E Omoto, et al.
Bone Marrow Transplantation|July 22, 1999
Successful treatment of advanced natural killer cell lymphoma with high-dose chemotherapy and syngeneic peripheral blood stem cell transplantationY Nawa, K Takenaka, K Shinagawa, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 17, 2000
[Effect of etoposide added to individualized induction therapy of adult acute myeloid leukemia--the JALSG-AML-92 Study. Japan Adult Leukemia Study Group]S Miyawaki, M Tanimoto, T Kobayashi, et al.
Bone Marrow Transplantation|June 1, 2000
G-CSF reduces IFN-gamma and IL-4 production by T cells after allogeneic stimulation by indirectly modulating monocyte functionY Nawa, T Teshima, K Sunami, et al.
Annals of Hematology|June 1, 1997
Evaluation of bone marrow iron by magnetic resonance imagingM Isokawa, F Kimura, T Matsuki, et al.
Annals of Hematology|August 6, 1998
Myelodysplastic syndrome with translocation (8;21): a distinct myelodysplastic syndrome entity or M2-acute myeloid leukemia with extensive myeloid maturation?K Kojima, E Omoto, M Hara, et al.
International Journal of Hematology|August 26, 1998
Graft rejection and recovery of host-derived hematopoiesis after allogeneic bone marrow transplantation: relation to conditioning with high dose etoposide and total body irradiationM Hara, K Shinagawa, E Omoto, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
All-trans retinoic acid therapy for newly diagnosed acute promyelocytic leukemia: comparison with intensive chemotherapy. The Japan Adult Leukemia Study Group (JALSG)N Asou, K Adachi, J Tamura, et al.
Leukemia|April 1, 1996
Low-dose melphalan for treatment of high-risk myelodysplastic syndromesE Omoto, S Deguchi, S Takaba, et al.
Annals of Hematology|February 8, 2003
Cyclic thrombocytopenia and polycythemia veraK Kojima, N Fujii, E Omoto, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
British Journal of Haematology|April 1, 1997
Re-induction of complete remission with a new synthetic retinoid, Am-80, for relapse of acute promyelocytic leukaemia previously treated with all-trans retinoic acidM Takeuchi, T Yano, E Omoto, et al.
Bone Marrow Transplantation|July 22, 1999
Successful treatment of advanced natural killer cell lymphoma with high-dose chemotherapy and syngeneic peripheral blood stem cell transplantationY Nawa, K Takenaka, K Shinagawa, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 17, 2000
[Effect of etoposide added to individualized induction therapy of adult acute myeloid leukemia--the JALSG-AML-92 Study. Japan Adult Leukemia Study Group]S Miyawaki, M Tanimoto, T Kobayashi, et al.
Bone Marrow Transplantation|June 1, 2000
G-CSF reduces IFN-gamma and IL-4 production by T cells after allogeneic stimulation by indirectly modulating monocyte functionY Nawa, T Teshima, K Sunami, et al.
Annals of Hematology|June 1, 1997
Evaluation of bone marrow iron by magnetic resonance imagingM Isokawa, F Kimura, T Matsuki, et al.
Annals of Hematology|August 6, 1998
Myelodysplastic syndrome with translocation (8;21): a distinct myelodysplastic syndrome entity or M2-acute myeloid leukemia with extensive myeloid maturation?K Kojima, E Omoto, M Hara, et al.
International Journal of Hematology|August 26, 1998
Graft rejection and recovery of host-derived hematopoiesis after allogeneic bone marrow transplantation: relation to conditioning with high dose etoposide and total body irradiationM Hara, K Shinagawa, E Omoto, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
All-trans retinoic acid therapy for newly diagnosed acute promyelocytic leukemia: comparison with intensive chemotherapy. The Japan Adult Leukemia Study Group (JALSG)N Asou, K Adachi, J Tamura, et al.
Leukemia|April 1, 1996
Low-dose melphalan for treatment of high-risk myelodysplastic syndromesE Omoto, S Deguchi, S Takaba, et al.
Annals of Hematology|February 8, 2003
Cyclic thrombocytopenia and polycythemia veraK Kojima, N Fujii, E Omoto, et al.
Pageof 5